Chicago ... my question as well. They should have received their FDA letter by now, since it was confirmed the meeting was scheduled for early August, without cancellations. You would think it would be a race to a NR if there was something exciting or super encouraging to report. But who knows with these guys? I would also "assume" that whatever the result of the meeting, it would be material information for RVX interested parties, like investors?? 

Optimistically, and hopefully, Eversana is guiding the proper realistic outcome disclosures, and they are putting things together ... a good FDA meeting, plus financing strategy, would be optimal. Hopeful, but also understand that hope is not a strategy.

I will wait for Fuzz and others to hound IR, for generic answers, if we don't hear something soon.